The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...
The patient’s vital signs were also extracted, including heart rate, mean arterial pressure (MAP), respiratory rate ... failure (CHF), chronic obstructive pulmonary disease (COPD), liver disease, ...
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
Weight-loss surgery lowers risk of developing complications of liver disease in patients with cirrhosis and obesity. ScienceDaily . Retrieved February 17, 2025 from www.sciencedaily.com / releases ...
Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study offers one available option: bariatric surgery. Weight loss operations ...
However, where it fell short was with respect to the failure at week 36 with the phase 2b SYMMETRY study, which used EFX to treat compensated cirrhosis patients due to MASH stage F4 fibrosis.
Liver Disease-Focused Akero Therapeutics Stock Soars Over 100% On Monday - Here's Why On Monday, Akero Therapeutics, Inc. (NASDAQ:AKRO) released preliminary topline week 96 results from SYMMETRY ...
Cirrhosis is a condition in which scar tissue gradually replaces your healthy liver cells. It usually happens over a long period, often due to hepatitis, alcohol use disorder, or metabolic ...
Low-Level Traffic Air Pollution Linked to Liver Damage and Fatty Liver Disease Jan. 31, 2025 — Low levels of traffic-related air pollution harms the liver and may raise the risk of metabolic ...
Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...